MTRR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.746800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.258000E-01
Normal-vs-Stage2
1.665970E-01
Normal-vs-Stage3
1.483770E-02
Normal-vs-Stage4
6.000800E-01
Stage1-vs-Stage2
1.232790E-01
Stage1-vs-Stage3
2.386000E-02
Stage1-vs-Stage4
7.635400E-01
Stage2-vs-Stage3
7.784400E-02
Stage2-vs-Stage4
3.720200E-01
Stage3-vs-Stage4
2.138000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.398780E-01
Normal-vs-AfricanAmerican
9.256400E-01
Normal-vs-Asian
3.231200E-01
Caucasian-vs-AfricanAmerican
2.549600E-02
Caucasian-vs-Asian
5.414000E-01
AfricanAmerican-vs-Asian
2.281400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.567350E-01
Normal-vs-Female
2.182800E-01
Male-vs-Female
5.192400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.313600E-01
Normal-vs-Age(41-60Yrs)
3.310600E-01
Normal-vs-Age(61-80Yrs)
1.402370E-01
Normal-vs-Age(81-100Yrs)
1.231770E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.191600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.177400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.774600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.276100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.086410E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.760600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.555500E-02
Normal-vs-Daily Drinker
7.340300E-02
Normal-vs-Weekly Drinker
1.656160E-01
Normal-vs-Occasional Drinker
3.076800E-01
Normal-vs-Social Drinker
1.817770E-01
Non Drinker-vs-Daily Drinker
4.986600E-01
Non Drinker-vs-Weekly Drinker
5.816000E-01
Non Drinker-vs-Occasional Drinker
1.333050E-01
Non Drinker-vs-Social Drinker
4.334400E-01
Daily Drinker-vs-Weekly Drinker
3.339400E-01
Daily Drinker-vs-Occasional Drinker
7.516000E-02
Daily Drinker-vs-Social Drinker
2.416400E-01
Weekly Drinker-vs-Occasional Drinker
4.672000E-01
Weekly Drinker-vs-Social Drinker
8.625600E-01
Occasional Drinker-vs-Social Drinker
5.691600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.028800E-01
Normal-vs-Grade 2
7.235200E-01
Normal-vs-Grade 3
7.585800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.246400E-01
Grade 1-vs-Grade 3
7.120000E-01
Grade 1-vs-Grade 4
4.028800E-01
Grade 2-vs-Grade 3
4.932000E-01
Grade 2-vs-Grade 4
7.235200E-01
Grade 3-vs-Grade 4
7.585800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.826100E-02
Normal-vs-NonDiabetic
1.117570E-01
Diabetic-vs-NonDiabetic
2.102600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.767770E-01
Normal-vs-NoPancreatitis
9.764300E-02
Pancreatitis-vs-NoPancreatitis
8.631000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.727200E-01
Normal-vs-N1
1.417790E-01
N0-vs-N1
7.132600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.716800E-01
Normal-vs-TP53-NonMutant
5.294400E-01
TP53-Mutant-vs-TP53-NonMutant
2.321400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
